Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-Year follow-up of the Danish randomized DBCG-82TM protocol

Acta Oncologica

Volumn 47, Issue 4, 2008, Pages 672-681

  Blichert Toft, Mogens ^a   Nielsen, Maja ^a   Düring, Maria ^a   Møller, Susanne ^a   Rank, Fritz ^a   Overgaard, Marie ^b   Mouridsen, Henning T ^a  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; SURVIVAL TIME; TIME SERIES ANALYSIS; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST TUMOR; MIDDLE AGED; PAGET NIPPLE DISEASE; SEGMENTAL MASTECTOMY; SURVIVAL RATE; TUMOR RECURRENCE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 45149086630     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860801971439     Document Type: Article

References (33)

1. Keynes G. Conservative treatment of breast cancer. Br J Surg 1932;19:415-80.
2. Atkins H, Hayward JL, Klugman DJ, Wayte AB. Treatment of early breast cancer: A report after ten years of a clinical trial. Br Med J 1972;2:423-9.
3. Mustakallio S. Conservative treatment of breast carcinoma-Review of 25 years follow up. Clin Radiol 1972;23:110-6.
4. Hayward JL. The Guy?s trial of treatments of early breast cancer. World J Surg 1977;1:314-6.
5. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32.
6. Sarrazin D, Le M, Rouesse J, Contesso J, Petit JY, Lacour J, et al. Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less. The experience of the Institut Gustave-Roussy. Cancer 1984;53:1209-13.
7. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
8. Dongen JA van, Voogd AC, Fentiman IS, Legrand C, Sylvester J, Tong D, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst 2000;92:1143-50.
9. Straus K, Lichter A, Lippman M, Danforth D, Swain S, Cowan K, et al. Results of the National Cancer Institute Early Breast Cancer Trial. J Natl Cancer Inst Monogr 1992;11:27-32.
10. Blichert-Toft M, Rose C, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. J Natl Cancer Inst Monogr 1992;11:19-25.
11. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-5.
12. Voogd A, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two European randomized trials. J Clin Oncol 2001;19:1688-97.
13. Kroman N, Holtveg H, Wohlfahrt J, Jensen M-B, Mouridsen HT, Blichert-Toft M, et al. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 2004;100:688-93.
14. Kurtz JM, Spitalier J-M, Amalric R, Brandone H, Ayme Y, Bressac C, et al. Mammary recurrence in women younger than forty. Int J Radiat Oncol Biol Phys 1988;15:271-6.
15. Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999;44:1005-15.
16. Malmström P, Holmberg L, Anderson H, Mattsson J, Jönsson P-E, Tennvall-Nittby L, et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: A randomised clinical trial in a population with access to public mammography screening. Eur J Cancer 2003;39:1690-7.
17. Harris JR, Connolly JL, Schnitt SJ, Cady B, Love S, Osteen RT, et al. The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy. Ann Surg 1985;2001:164-9.
18. Locker AP, Ellis IO, Morgant DAL, Elston CW, Mitchell A, Blamey RW, et al. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 1989;76:890-4.
19. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:949-55.
20. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
21. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen. Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet 1999;353:1641-8.
22. Zelen M. A new design for randomized clinical trials. N Engl J Med 1979;300:1242-5.
23. Danish Breast Cancer Cooperative Group, DBCG (eds). The structure and organization of DBCG. www.dbcg.dk Copenhagen, 2004.
24. Andersen D, Hilsted J, Riis P, Walter S. The DBCG case. Annual Report, The Danish Committee on Scientific Dishonesty, DCSD. Copenhagen, pp 79-81, 1995.
25. Danish Breast Cancer Cooperative Group (eds). Protocol collection of DBCG manuals. DBCG Secretariat, Copenhagen 1982;2:1-121. (In Danish.)
26. Ottesen G, Andersen JA, Blichert-Toft M, Axelsson C. Frequency and types of chest wall recurrences among node negative breast cancer patients. Acta Oncol 1988;27:601-4.
27. Zedeler K. Assessment and presentation of survival experience in the Danish Breast Cancer Cooperative Group. Acta Oncol 1988;27:649-62.
28. Langlands AO, Pocock SJ, Kerr GR, Gore SM. Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J 1979;2:1247-51.
29. Rutqvist LE, Wallgren A, Nilsson B. Is breast cancer a curable disease? A study of 14731 women with breast cancer from the cancer registry of Norway. Cancer 1984;53:1793-800.
30. Blichert-Toft M, Mouridsen HT, Andersen KW. Clinical trials. Seminars Surg Oncol 1996;12:32-8.
31. Rutgers EJTh for the EUSOMA Consensus Group. Quality control in the locoregional treatment of breast cancer. EJC 2001;37:447-53.
32. Smith TE, Lee D, Turner BC, Carter D, Haffty BG. True recurrence vs. new primary ipsilateral breast tumor relapse: An analysis of clinical and pathological differences and their implications in natural history, progress, and therapeutic management. Int J Radiat Oncol Biol Phys 2000;48:1281-9.
33. Johansen J, Overgaard J, Rose C, Engelholm SAa, Gadeberg CC, Kjaer M et al. On behalf of DBCG. Cosmetic outcome and breast morbidity in breast conserving treatment. Results from the DBCG-82TM national randomized trial in breast cancer. Acta Oncol 2002;41:369-80.